Tag: Amgen

Repatha Linked to Lower Death Risk in High-Risk Patients Without Previous Heart Attack or Stroke

Amgen reports Phase 3 findings showing Repatha reduced death risk in high-risk…

ME Desk

Amgenโ€™s Cancer Therapy Meets Key Goal in Phase 3 Gastric Cancer Study

Amgen announced the Phase 3 FORTITUDE-101 clinical trial evaluating first-line bemarituzumab plus chemotherapy (mFOLFOX6)…

ME Desk